Provided by Tiger Trade Technology Pte. Ltd.

HUA MEDICINE-B

3.620
+0.1805.23%
Volume:3.85M
Turnover:13.83M
Market Cap:3.83B
PE:2.85
High:3.660
Open:3.500
Low:3.440
Close:3.440
52wk High:4.950
52wk Low:1.870
Shares:1.06B
HK Float Shares:1.06B
Volume Ratio:1.32
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.268
ROE:254.05%
ROA:-6.04%
PB:3.30
PE(LYR):2.85
PS:6.73

Loading ...

Hua Medicine Maintains Share Capital Stability in April; Minor Option Cancellation Recorded

Bulletin Express
·
May 07

华领医药2025年业绩扭亏为盈,核心糖尿病药物销售与研发协同推动增长

Bulletin Express
·
Apr 22

Hua Medicine Posts First-Ever Annual Profit on 93% Revenue Surge, Strengthens ESG Performance

Bulletin Express
·
Apr 22

Hua Medicine to Hold 2026 AGM; Seeks Fresh Authorisations for 10% Share Buy-back, 20% Issuance Mandate and New Articles Adoption

Bulletin Express
·
Apr 22

HUA MEDICINE-B Publishes 2025 Annual Report and AGM Circular, Opens Channels for Shareholder Communication

Bulletin Express
·
Apr 22

Hua Medicine releases 2025 Annual Report and dispatches AGM circular on director re-election, share mandates and auditor appointment

Bulletin Express
·
Apr 22

Hua Medicine announces annual general meeting

Reuters
·
Apr 22

Hua Medicine publishes 2025 annual report

Reuters
·
Apr 22

Hua Medicine Seeks Shareholder Nod for Fourth Amended and Restated Memorandum and Articles to Facilitate Electronic and Hybrid Meetings

Bulletin Express
·
Apr 16

Hua Medicine proposes bylaw changes to allow electronic, hybrid shareholder meetings

Reuters
·
Apr 16

Hua Medicine Turns to 2025 Profit; Shares Soar 10%

MT Newswires Live
·
Mar 27

HUA MEDICINE-B (02552) 2025 Annual Report Review: Deciphering the Long-Term Growth Rationale of the GKA Leader Following its First Annual Profit

Stock News
·
Mar 27

Hua Medicine-B Surges Over 14% in Morning Trading on Record 2025 Profit Outlook

Deep News
·
Mar 27

Stock Track | Hua Medicine-B Soars 5.14% Intraday on Strong 2025 Earnings and Record Profitability

Stock Track
·
Mar 27

Hua Medicine Achieves Record Profitability in 2025 with Dorzagliatin Sales Exceeding 4 Million Boxes

Stock News
·
Mar 27

BRIEF-Hua Medicine Posts Profit For The Year RMB1.11 Billion

Reuters
·
Mar 26

Hua Medicine FY2025 profit before tax jumps to RMB 1.1 billion; revenue rises 93% to RMB 493 million

Reuters
·
Mar 26

Hua Medicine FY2025 dorzagliatin revenue rises to CNY 493 million; gross margin climbs to 56.9% due to higher manufacturing efficiency

Reuters
·
Mar 26

Hua Medicine FY Revenue RMB 492.9 Million

THOMSON REUTERS
·
Mar 26

Hua Medicine Names Nelly Au-Yeung as Company Secretary and Authorised Representative, Succeeding Winnie Yuen

Bulletin Express
·
Mar 26